Temple University School of Pharmacy researcher Ho-Lun Wong received a five year, $1.6 million grant from the National Institutes of Health to further his research into using nanotechnology to treat latter-stage prostate cancer. The assistant professor of pharmaceutical sciences is studying the potential of using nanoparticles as a delivery system for an RNA-based drug that targets prostate cancer cells.